Ceftaroline (Zinforo®)

Assessment Status Rapid Review complete
Drug Ceftaroline
Brand Zinforo®
Indication For the treatment of adult patients with complicated Skin and Soft Tissue Infections (cSSTI) or Community Acquired Pneumonia (CAP).
Assessment Process
Rapid review commissioned 08/10/2012
Rapid review completed 12/10/2012
Rapid review outcome Full pharmacoeconomic evaluation not recommended for HCV genotype 3 infection